Published in Thromb Res on January 04, 2006
Cancer-associated thrombosis: an overview. Clin Med Insights Oncol (2014) 1.23
Epidemiology of cancer-related venous thromboembolism. Best Pract Res Clin Haematol (2009) 1.11
Incidental pulmonary embolism in cancer patients: clinical characteristics and outcome--a comprehensive cancer center experience. Vasc Health Risk Manag (2011) 0.95
Venous thromboembolic disease. J Natl Compr Canc Netw (2011) 0.93
Risk factors and incidence of thromboembolic events (TEEs) in older men and women with breast cancer. Ann Oncol (2011) 0.89
Chemotherapy-associated thromboembolic risk in cancer outpatients and effect of nadroparin thromboprophylaxis: results of a retrospective analysis of the PROTECHT study. J Transl Med (2011) 0.89
The prothrombotic activity of cancer cells in the circulation. Blood Rev (2015) 0.88
Thrombosis and cancer. Nat Rev Clin Oncol (2012) 0.88
The potential benefits of low-molecular-weight heparins in cancer patients. J Hematol Oncol (2010) 0.87
Long-term activation of the pro-coagulant response after neoadjuvant chemoradiation and major cancer surgery. Br J Cancer (2009) 0.84
Biomolecular markers of cancer-associated thromboembolism. Crit Rev Oncol Hematol (2013) 0.84
Real-Time Label-Free Embolus Detection Using In Vivo Photoacoustic Flow Cytometry. PLoS One (2016) 0.82
Impact of chemotherapy on venous thromboembolism: comment to: regional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and Thrombosis Study. Haematologica (2013) 0.80
Cancer-associated thrombosis. Open Cardiovasc Med J (2010) 0.80
The incidence and predictors of thromboembolic events in patients with lung cancer. ScientificWorldJournal (2014) 0.80
Venous thromboembolism in the cancer population: pathology, risk, and prevention. J Adv Pract Oncol (2012) 0.79
Venous thromboembolism in cancer patients: an underestimated major health problem. World J Surg Oncol (2015) 0.79
Impact of venous thromboembolism on mortality of elderly Medicare patients with stage III colon cancer. Oncologist (2012) 0.78
Incidence of Venous Thromboembolism Following Laparoscopic Surgery for Gastrointestinal Cancer: A Single-Center, Prospective Cohort Study. World J Surg (2016) 0.78
Changes in the expression of plasma proteins associated with thrombosis in BRCA1 mutation carriers. J Cancer Res Clin Oncol (2012) 0.77
Early changes of a novel APC-dependent thrombin generation assay during chemotherapy independently predict venous thromboembolism in cancer patients--a pilot study. Support Care Cancer (2012) 0.77
Increased Levels of NF-kB-Dependent Markers in Cancer-Associated Deep Venous Thrombosis. PLoS One (2015) 0.77
The Impact of Cancer on the Clinical Outcome of Patients After Inferior Vena Cava Filter Placement: A Retrospective Cohort Study. Am J Clin Oncol (2016) 0.76
Management of venous thromboembolism in patients with cancer: role of dalteparin. Vasc Health Risk Manag (2008) 0.75
Severe hepatic dysfunction is associated with venous thromboembolic events in phase 1 clinical trials. Thromb Res (2015) 0.75
High rates of venous thromboembolic events in patients undergoing systemic therapy for urothelial carcinoma: A systematic review and meta-analysis. Urol Oncol (2016) 0.75
The application of clinical variables and models to predict pulmonary embolism in cancer patients: a comprehensive single cancer center experience. Patient Prefer Adherence (2013) 0.75
Mesenteric ischemia after capecitabine treatment in rectal cancer and resultant short bowel syndrome is not an absolute contraindication for radical oncological treatment. Radiol Oncol (2015) 0.75
Cancer and thrombosis: recent advances. Curr Oncol (2008) 0.75
Prognostic value of routine laboratory variables in prediction of breast cancer recurrence. Sci Rep (2017) 0.75
Thromboembolic disease in cancer patients. Support Care Cancer (2013) 0.75
A systems medicine approach for finding target proteins affecting treatment outcomes in patients with non-Hodgkin lymphoma. PLoS One (2017) 0.75
Identifying ischemic stroke associated with cancer: a multiple model derived from a case-control analysis. J Neurol (2017) 0.75
Cholecystitis as the presenting manifestation of acute myeloid leukemia: report of a case. Am J Hematol (2002) 0.83
Pathway-based pharmacogenomics of gemcitabine pharmacokinetics in patients with solid tumors. Pharmacogenomics (2012) 0.79
Neoadjuvant chemoradiotherapy for locally advanced pancreas cancer rarely leads to radiological evidence of tumour regression. HPB (Oxford) (2012) 0.78
Severe electrolyte disturbances after hyperthermic intraperitoneal chemotherapy: oxaliplatin versus mitomycin C. Ann Surg Oncol (2010) 0.77
Neoadjuvant interferon-based chemoradiation for borderline resectable and locally advanced pancreas cancer: a Phase II pilot study. HPB (Oxford) (2013) 0.75